Movicol laxative

Movicol is a widely recognized pharmaceutical product used for the treatment of chronic constipation and fecal impaction. It was originally developed by Norgine, a leading European specialist pharmaceutical company. The product works through an osmotic mechanism, using macrogol 3350 to help retain water in the bowel.

Movicol is manufactured in several locations across Europe to meet global demand, with significant production facilities located in the United Kingdom and Germany. The brand remains under the ownership of Norgine, which is headquartered in the Netherlands and operates as an independent private company with a strong focus on gastroenterology.